CNP and atherosclerosis: Therapeutics designed to bind to the cognate receptors for CNP could have wide-ranging clinical applications in diseases such as hypertension, atherosclerosis, restenosis, critical limb ischaemia, peripheral arterial disease, I/R injury, MI, HF, and heart rhythm disorders.